A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy ; volume:14 ; number:1 ; day:29 ; month:9 ; year:2014 ; pages:1-9 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (29.9.2014), 1-9, 12.2014
- Creator
-
Canipe, Ashley
- Contributor
-
Chidumayo, Takondwa
Blevins, Meridith
Bestawros, Michael
Bala, Jay
Kelly, Paul
Filteau, Suzanne
Shepherd, Bryan E.
Heimburger, Douglas C.
Koethe, John R.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-521
- URN
-
urn:nbn:de:1111-2016030314356
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Canipe, Ashley
- Chidumayo, Takondwa
- Blevins, Meridith
- Bestawros, Michael
- Bala, Jay
- Kelly, Paul
- Filteau, Suzanne
- Shepherd, Bryan E.
- Heimburger, Douglas C.
- Koethe, John R.
- SpringerLink (Online service)
Other Objects (12)
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia
Interruption of antiretroviral treatment in HIV-infected children
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy
Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa
Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia
Interruption of antiretroviral treatment in HIV-infected children
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy
Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa
Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda
Hematological and clinical profiles of HIV-infected adults initiating Highly Active AntiRetroviral Therapy (Haart) in Uganda
Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia
Interruption of antiretroviral treatment in HIV-infected children
Outcomes in antiretroviral-naive HIV-infected patients initiating therapy with TDF/FTC plus either atazanavir/r or another third recommended drug
Plasma lipidome abnormalities in people with HIV initiating antiretroviral therapy
Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa
Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
Decreased bone turnover in HIV-infected children on antiretroviral therapy